Analysis of esophagogastric cancer patients enrolled in National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP)-sponsored phase I trials

被引：5
|
作者：
Bando, Hideaki
Rubinstein, Larry
Harris, Pamela Jo
Yoshino, Takayuki
Doi, Toshihiko
Ohtsu, Atsushi
Welch, Jack
Takebe, Naoko
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[2] Div Canc Treatment & Diag, Bethesda, MD USA
[3] NCI, NIH, Bethesda, MD 20892 USA
[4] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[5] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
[6] Canc Therapy Evaluat Program, Invest Drug Branch, Rockville, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials
    Bando, Hideaki
    Rubinstein, Larry
    Harris, Pamela
    Yoshino, Takayuki
    Doi, Toshihiko
    Ohtsu, Atsushi
    Welch, John
    Takebe, Naoko
    GASTRIC CANCER, 2017, 20 (03) : 481 - 488
  • [2] Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials
    Hideaki Bando
    Larry Rubinstein
    Pamela Harris
    Takayuki Yoshino
    Toshihiko Doi
    Atsushi Ohtsu
    John Welch
    Naoko Takebe
    Gastric Cancer, 2017, 20 : 481 - 488
  • [3] Analysis of Lung Cancer Patients Enrolled in CTEP (Cancer Therapy Evaluation Program)-Sponsored Phase I Trials
    Gadgeel, Shirish M.
    Ivy, Percy
    Chen, Wei
    Mauer, Joan
    Smith, Daryn
    LoRusso, Patricia
    CLINICAL LUNG CANCER, 2011, 12 (04) : 218 - 223
  • [4] Characteristics and outcome of breast cancer patients enrolled in cancer therapy evaluation program (CTEP) sponsored phase I clinical trials
    Lynce, Filipa
    Rubinstein, Larry
    Harris, Pamela
    CANCER RESEARCH, 2015, 75
  • [5] Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials
    Lynce, Filipa
    Blackburn, Matthew J.
    Cai, Ling
    Wang, Heping
    Rubinstein, Larry
    Harris, Pamela
    Isaacs, Claudine
    Pohlmann, Paula R.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 35 - 41
  • [6] Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials
    Filipa Lynce
    Matthew J. Blackburn
    Ling Cai
    Heping Wang
    Larry Rubinstein
    Pamela Harris
    Claudine Isaacs
    Paula R. Pohlmann
    Breast Cancer Research and Treatment, 2018, 168 : 35 - 41
  • [7] Pediatric drug development: A perspective from the cancer therapy evaluation program (CTEP) of the National Cancer Institute (NCI)
    Smith, M
    Ho, PTC
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (01) : 11 - 22
  • [8] Prognostic factors for 90-day mortality in patients with solid malignancies treated on Phase 1 trials sponsored by the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute.
    Wong, Kit Man
    Rubinstein, Larry
    Rinker, Matthew
    Smith, Gary Lee
    Sharon, Elad
    Eckhardt, S. Gail
    Messersmith, Wells A.
    Leong, Stephen
    Harris, Pamela Jo
    Gao, Dexiang
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Analysis of small cell lung cancer (SCLC) patients (Pts) treated on cancer therapy evaluation program (CTEP)-sponsored phase I trials: 1992-2012.
    Forde, Patrick M.
    Hooker, Craig M.
    Rubinstein, Larry
    Hann, Christine L.
    Harris, Pamela Jo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] The potential to backfill in phase I trials: the National Cancer Institute's Cancer Therapy Evaluation Program experience
    Foster, Jared C.
    Korn, Edward L.
    Freidlin, Boris
    Moscow, Jeffrey A.
    JNCI CANCER SPECTRUM, 2023, 7 (06)
12345